Ara
Toplam kayıt 20, listelenen: 1-10
IgG Neutralizing Antibodies to SARS-CoV-2 Among Healthcare Workers Who Frequently Encountered Patients with COVID-19
(2022)
Introduction: Since the Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) first emerged in Wuhan, on 12 December 2019, it has spread rapidly across the world and developed into a pandemic. As healthcare workers ...
The Impacts of 13 Novel Mutations of SARS-Cov-2 on Protein Dynamics: in Silico Analysis From Turkey
(2022)
SARS-CoV-2 inherits a high rate of mutations making it better suited to the host since its fundamental role in evolution is to provide diversity into the genome. This research aims to identify variations in Turkish isolates ...
Assessment of Endodontic Emergency Care in a COVID-19 Pandemic
(2022)
Objective: This study compared the aerosol-generating and non-aerosol -generating endodontic emergency procedures' success and assessed the outcome of endodontic treatments initiated before a pandemic but could not be ...
Covid-19 tanısı olan hastalara bakım veren hemşirelerin deneyimlerinin ve biyopsikososyal açıdan nasıl etkilendiklerinin incelenmesi
(Başkent Üniversitesi Sağlık Bilimleri Enstitüsü, 2021)
Bu araştırma, covid-19 tanısı olan bireylere bakım veren hemşirelerin deneyimlerinin ve biyo-psikososyal açıdan nasıl etkilendiklerinin incelenmesi amacıyla planlanmıştır. Araştırma tanımlayıcı ve niteliksel tipte bir ...
Allergen fragrance molecules: a potential relief for COVID-19
(2021)
BackgroundThe latest coronavirus SARS-CoV-2, discovered in China and rapidly spread Worldwide. COVID-19 affected millions of people and killed hundreds of thousands worldwide. There are many ongoing studies investigating ...
Tobacco and COVID-19
(2020)
Tobacco and its products are the well-known causes of premature deaths associated with cancer, cardiovascular disease, and chronic obstructive pulmonary disease, as well as they constitute a significant risk factor that ...
Conjunctivitis as sole symptom of COVID-19: A case report and review of literature
(2020)
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus causing an ongoing pandemic in 2020. Although the symptomatic patients infected by SARS-CoV-2 generally show respiratory distress, ...
Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR(-/-) mice
(2020)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently a global pandemic with unprecedented public health, economic and social impact. The development of effective mitigation strategies, therapeutics and ...
The Changing Dynamics Of Neutralizing Antibody Response Within 10 Months Of SARS-Cov-2 Infections
(2022)
There are limited data on how long neutralizing antibody (NAb) response elicited via primary SARS-CoV-2 infection will last. Eighty-four serum samples were obtained from a prospective cohort of 42 laboratory-confirmed ...
Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin
(2022)
Purpose As of July 2022, the COVID-19 pandemic has affected over 555 million worldwide confirmed cases and caused more than 6.3 million deaths. The studies showed that the D-dimer levels were increased in non-survivors ...